elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Triple-negative breast cancer
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Triple-negative breast cancer
RIS
0.002
(Research Intensity Score)
Papers
227
Top papers
Metabolic Targeting of Oxidative Phosphorylation Enhances Chemosensitivity in Triple-Negative Breast Cancer via a Synergistic Nanomedicine
2025 · 52 citations
Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)
2024 · 78 citations
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
2021 · 315 citations
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
2025 · 53 citations
Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis
2025 · 46 citations
Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death
2024 · 68 citations
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
2025 · 46 citations
HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
2025 · 43 citations
AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer
2025 · 42 citations
Newest papers
Sacituzumab Govitecan overcomes carboplatin resistance in TNBC through enhancing METTL3/METTL14/YTHDF1/PRMT5 axis-mediated ferroptosis
2026
Desing of Novel 1,4-Naphthoquinone Derivatives: Evaluation of Apoptotic Effects and Anticancer Activity Against Triple Negative Breast Cancer Cells with Molecular Docking and Molecular Dynamics Studies
2026
DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer
2026
Study of the therapeutic potential of a novel palladium- acylthiourea metal complex in the elimination of triple negative breast cancer stem cells
2026
Rapid relapse in triple-negative breast cancer: clinical patterns, platinum resistance, and implications for clonal evolution
2026
Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix–Targeted Radiopharmaceutical against Triple-Negative Breast Cancer
2026 · 2 citations
SLC22A3 regulates ferroptosis in the mesenchymal subtype of triple-negative breast cancer by modulating histone H3K4 serotonylation
2026
Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology
2026
Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer
2026
Browse all papers →
Triple-negative breast cancer's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Triple-negative breast cancer's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link